Prime Medicine, Inc.PRMENASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-6.40%
↑ 82% vs avg
Percentile
P48
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-34.84%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -6.40% |
| Q3 2025 | 17.91% |
| Q2 2025 | 16.18% |
| Q1 2025 | -454.77% |
| Q4 2024 | 153.16% |
| Q3 2024 | 42.63% |
| Q2 2024 | 32.33% |
| Q1 2024 | -53.23% |
| Q4 2023 | -8.63% |
| Q3 2023 | 1.69% |
| Q2 2023 | 1.75% |
| Q1 2023 | -22.61% |
| Q4 2022 | -1.83% |
| Q3 2022 | -39.42% |
| Q2 2022 | 52.32% |
| Q1 2022 | -286.77% |
| Q4 2021 | -18.71% |
| Q3 2021 | -55.76% |
| Q2 2021 | -24.48% |
| Q1 2021 | -111.90% |
| Q4 2020 | 0.00% |
| Q4 2019 | 0.00% |